Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPO Update: Haircuts Needed To Price Biotech Offerings

Executive Summary

The two drug developers that managed to launch initial public offerings in the US during the past two weeks had to accept rough haircuts in order to get investors to buy their newly issued stock.

Advertisement

Related Content

Half of 2016 Biotech IPOs Positive At Mid-Year; 2015 Success Rate Sours
VC Roundup: Annexon, Mersana Benefit As Investors Favor Private Over Public Biotechs
IPO Update: With No New Offerings, Kadmon Steals The Spotlight
AC Immune Targeting $50m IPO
IPO Update: Three More Biotechs Squeeze Through The Window
Soon-Shiong Envisions Better, Ultimately Cheaper Cancer Care
VC Round-Up: Microbiome Focused Lodo, T-Cell Firm Tmunity, And More
FINANCE ROUNDUP: Six VC financings and a royalty deal
Sanofi opts into second license with Selecta

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC065351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel